“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
10x Genomics, Inc. TXG recently began commercial shipments of Atera, its next-generation spatial biology platform designed to combine whole-transcriptome analysis, sub-cellular resolution and ...
According to MarketsandMarkets™, the Spatial Genomics & Transcriptomics Market is projected to reach USD 1.23 billion by 2031 from USD ...
10x Genomics announced the launch of Atera, a new in situ spatial biology platform designed to deliver whole-transcriptome analysis with single-cell sensitivity at unprecedented scale. The Atera ...
Atera could meaningfully boost instrument sales in late 2026 and drive recurring high-margin consumables revenue from 2027 onward. TXG’s valuation already prices in significant Atera success, but the ...
Study aims to identify biomarkers that could predict how patients with breast cancer respond to neoadjuvant therapy.
The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results